Directory
>
Mark Schneyer
Mark Schneyer
Director | Acadia Pharmaceuticals Inc.
New York, New York, United States
Mark Schneyer
Summary
Mark Schneyer is a seasoned executive in the pharmaceutical industry, currently serving as the Chief Financial Officer at Acadia Pharmaceuticals. With a robust background in finance and business development, he plays a pivotal role in steering the company's strategic direction, particularly in neuroscience and rare diseases. His extensive experience spans leadership positions at Pfizer, where he led various business development initiatives, and Lazard, where he advised on high-profile M&A transactions. Mark's multifaceted expertise encompasses commercialization, investor relations, and operations, making him a key player in driving innovation within the healthcare sector. He is passionate about addressing unmet medical needs and has a proven track record of navigating complex financial landscapes. Mark's educational foundation from the Wharton School further complements his professional journey, equipping him with the analytical skills necessary for strategic decision-making.
Mark Schneyer
Work Experience
Chief Financial Officer at
Acadia Pharmaceuticals Inc.
December 2021 - Present
Mark Schneyer
Education
Wharton School
January 1992 - January 1996
Frequently Asked Questions about Mark Schneyer
What is Mark Schneyer email address?
Mark Schneyer's primary email address is *************@acadia.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Mark Schneyer work for?
Mark Schneyer is a Director at Acadia Pharmaceuticals Inc..
Where Mark Schneyer graduated from?
Mark Schneyer holds a degree in null from Wharton School.
How can I directly contact Mark Schneyer?
To contact Mark Schneyer directly, you can use the email address *************@acadia.com. Complete contact information is available upon registration with Muraena.
Who is Mark Schneyer?
Mark Schneyer is a seasoned executive in the pharmaceutical industry, currently serving as the Chief Financial Officer at Acadia Pharmaceuticals. With a robust background in finance and business development, he plays a pivotal role in steering the company's strategic direction, particularly in neuroscience and rare diseases. His extensive experience spans leadership positions at Pfizer, where he led various business development initiatives, and Lazard, where he advised on high-profile M&A transactions. Mark's multifaceted expertise encompasses commercialization, investor relations, and operations, making him a key player in driving innovation within the healthcare sector. He is passionate about addressing unmet medical needs and has a proven track record of navigating complex financial landscapes. Mark's educational foundation from the Wharton School further complements his professional journey, equipping him with the analytical skills necessary for strategic decision-making.
Mark`s contact details
*************@acadia.com
*********@acadia-pharm.com
Colleagues
Associate Director, Sales Operations and other Sales and Sales Leadership Roles
Group Leader - Novel Target Discovery and Validation Group
Scientist
Commercial Services
Certified Public Accountant
Clinical Research Associate
Analyst (formerly Defined Health)
Sales Representative / Account Management.
Director, QA
Assistant Professor Department of Pediatrics